4[2]Alexandra R,Renee K,Carl J.Inflammation in atherosclerosis:some thoughts about acute coronary syndromes[J].Circulation,2006,113:728-732.
5[4]Yarnell JW,Baker IA,Sweetnam PM,et al.Fibrinogen,viscosity and white blood cell count are major risk factors for ischemic heart disease[J].The caerphilly and speedwell collaborative heart disease studies.Circulation,1991,83(3):836-44.
6[6]Tschaikowsky K,Meisner M,Schonhuber F,et al.Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-ylxanthogenate(D609)[J].Br J Pharmacol,1994,113:664-668.
7[7]Tschaikowsky K,Schmidt J,Meisner M.Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C[J].J Pharmacol Exp Ther,1998,285(2):800-804.
8[8]Wu X,Lu H,Zhou L,et al.Changes of phosphatidylcholine-specific phospholipase C in hepatocarcinogenesis and in the proliferation and differentiation of rat liver cancer cells[J].Cell Biol Int,1997,21(6):375-81.
9Wu X Z，Cell Biol Int，1997年，21卷，6期，375页
10SUGIMORI D, NAKAMURA M. Partial purification and some properties of a phospholipase C from Pseudomonas sp. strain KS3.2[J]. Biosci Biotechnol Biochem, 2006(70): 535- 537.
